Foundation Medicine
Foundation Medicine is a Massachusetts-based biotechnology company that provides genomic profiling assays and clinical trail matching solutions for oncology research centers.
Business Model:
Revenue: $350M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Foundation Medicine Information
Foundation Medicine was acquired by
Roche.
The acquisition happend on 2015-01-12.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 150 Second Street
City: Cambridge
State: MA
Zip: 02141
Country: US
Financial Info
Stage:
series b
Raised Last:
$14M
Raised Total:$97M
Social
Metrics
1,174,889Website Global Rank
26,213Website Monthly Traffic
Twitter Followers
Description
Foundation Medicine is a Massachusetts-based biotechnology company that provides genomic profiling assays and clinical trail matching solutions for oncology research centers.
Contact Phone:
+16174182200
Contact Email:
Foundation Medicine went public on 9/25/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/25/2013
IPO Valuation:
$486M
Ticker Symbol:
FMI
IPO Price:
$18/share
Amount Raised:
$106M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2016 | COTA Healthcare | Series B | - |
| 5/2016 | COTA Healthcare | Series B | - |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2012 | Series B | $42.5M |
Deerfield Management Casdin Capital, LLC Redmile Group WuXi Healthcare Ventures Third Rock Ventures Google Ventures Kleiner Perkins Caufield & Byers |
8/2011 | Series A | $10M |
Third Rock Ventures Kleiner Perkins Caufield & Byers Google Ventures |
3/2010 | Series A | $7M |
Third Rock Ventures |
9/2013 | IPO | $106M | 1/2013 | Series B | 2 | $13.5M |
Evan Jones Bill Gates Evan Jones Bill Gates |
9/2012 | Series B | 7 | $42.5M |
Third Rock Ventures Kleiner Perkins Casdin Capital Deerfield Capital Management GV Roche Venture Fund Redmile Group Third Rock Ventures Kleiner Perkins Casdin Capital Deerfield Capital Management GV Roche Venture Fund Redmile Group |
10/2011 | Series A | 3 | $33.5M |
GV Kleiner Perkins Third Rock Ventures GV Kleiner Perkins |
4/2010 | Venture Round | $7M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2020 | Lexent Bio |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
